logo

For the Inventor, By the Inventor

Winksele, Belgium

Desire J Collen

This inventor holds 11 USPTO granted patents. Top assignees: Leuven Research & Development Vzw, Kabivitrum Ab, Leuven Research & Development Vcw. Active years: 1979-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Desire J Collen. Retrieved from https://idiyas.com/inventor/desire-j-collen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 1.1

ph-index = 6

Forward Citations = 91(Granted Patents)


Location History:

  • Winksele, BE (1979 - 1986)
  • Louvain, BE (1988)
  • Winksele-Herent, BE (1992 - 1999)

Company Filing History:

goldMedal9 out of 26 
 
Leuven Research & Development Vzw
 patents
silverMedal1 out of 29 
 
Kabivitrum Ab
 patents
bronzeMedal1 out of 1 
 
Leuven Research & Development Vcw
 patent
4. 3 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1979-1999

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5951980 - Identification, production and use of new staphylokinase derivatives (1999-09-14),
2. 5695754 - Staphylokinase derivatives (1997-12-09),
3. 5336495 - Use of staphylokinase for the preparation of a pharmaceutical (1994-08-09),
4. 5174994 - Pharmaceutical composition having thrombolytic activity (1992-12-29),
5. 4752603 - Plasminogen activator and pharmaceutical composition having thrombolytic (1988-06-21),
6. 4623718 - Novel composition of matter of antithrombin III bound to a heparin (1986-11-18),
7. 4346029 - Antiplasmin and antiserum (1982-08-24),
8. 4216291 - Thrombosis-test (1980-08-05),
9. 4202872 - Determination of heparin in blood plasma (1980-05-13),
10. 4198335 - Antiplasmin and antiserum (1980-04-15),
11. 4180437 - Purification of antiserum for thrombosis test (1979-12-25),

Title: The Innovations of Desire J Collen

Introduction

Desire J Collen is a notable inventor based in Winksele, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of staphylokinase derivatives. With a total of 11 patents to his name, his work has the potential to impact medical treatments, especially in the area of arterial thrombosis.

Latest Patents

Collen's latest patents focus on the identification, production, and use of new staphylokinase derivatives. The methods involve preparing a DNA fragment that includes the coding sequence of staphylokinase, performing in vitro site-directed mutagenesis, and cloning the mutated DNA fragment into a suitable vector. The transformed host cells are then cultured to express the DNA fragment. His inventions also encompass pharmaceutical compositions that include these staphylokinase derivatives, aimed at treating arterial thrombosis.

Career Highlights

Throughout his career, Desire J Collen has worked with various organizations, including Leuven Research & Development Vzw. His innovative approaches and research have led to advancements in the production of staphylokinase derivatives, showcasing his expertise in molecular biology and genetic engineering.

Collaborations

Some of his notable collaborators include Dingeman C Rijken and Osamu Matsuo. Their combined efforts have contributed to the successful development of his patented technologies.

Conclusion

Desire J Collen's work exemplifies the intersection of innovation and medical science. His contributions to the field of biotechnology through his patents on staphylokinase derivatives highlight the importance of research in developing new treatments for critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…